about
Multiple Comorbid Conditions among Middle-Aged and Elderly Hemophilia Patients: Prevalence Estimates and Implications for Future Care.An inventory of healthy weight practices in federally funded haemophilia treatment centres in the United StatesRecombinant factor VIII in the management of hemophilia A: current use and future promise.The history and evolution of the clinical effectiveness of haemophilia type a treatment: a systematic review.Thrombin generation testing in haemophilia comprehensive care centres.The role of disease severity in influencing body mass index in people with haemophilia: a single-institutional cross-sectional study.Evidence supporting the use of recombinant activated factor VII in congenital bleeding disorders.The hope and reality of long-acting hemophilia products.Comorbidities and inhibitors in adult patients with haemophilia: issues, costs and management strategies.Major and Minor Classifications for Surgery in People With Hemophilia: A Literature Review.Promoting self-management and adherence during prophylaxis: evidence-based recommendations for haemophilia professionals.Evaluation of Heart Function in Patients With Hemophilia.Prevention of the musculoskeletal complications of hemophilia.Mortality, health care utilization and associated diagnoses in hospitalized patients with haemophilia in the United States: first reported nationwide estimates.Low-factor consumption for major surgery in haemophilia B with long-acting recombinant glycoPEGylated factor IX.Immune tolerance induction therapy for patients with hemophilia A and FVIII inhibitors particularly using low-dose regimens.Treatment trends for haemophilia A and haemophilia B in the United States: results from the 2010 practice patterns survey.Inhibition of tissue factor pathway inhibitor by the aptamer BAX499 improves clotting of hemophilic blood and plasma.Novel therapies and current clinical progress in hemophilia A.
P2860
Q35200471-2CE7A272-F1DD-4506-A60A-A06CD057F31BQ35794171-DEA57D71-10C2-4F03-A9F4-7A9B64EC17E6Q37230340-CE0D9321-E018-418C-97D1-98BF3AA90F71Q37578173-DFC5BDEC-4EEB-43C9-8CDF-30A4EB2E2B54Q37589662-A4ED3A0D-EADE-4F2B-B999-05FBE81FB92DQ37621263-FAEC911B-C079-4941-BD25-50B3B5EFD7C0Q37778291-C2F3C998-6538-493A-ADD8-0C5F5F2270DDQ37990479-0BC90AAB-E882-4AA5-84D1-D64EDCF32A26Q38613927-31FA5CCA-3EA7-4DAB-9953-6C06850D52E1Q38691560-5D628C68-07AB-4D5A-B48A-2EB99840D4BCQ38807701-E81F6CDD-36EC-475B-9C65-6E8A84D64725Q40354554-239B310E-3ECE-4521-862C-8B41CB597710Q41887730-91FAE663-DFB6-4E51-8AF5-E9949432DA7BQ43433675-133A406E-3182-40D2-9C07-41C358EE754DQ45856976-B8BACE91-39E8-471D-AD80-CA8F497CE696Q45872129-C50984FA-5362-4A98-9F6F-EFE7DE3D6861Q45878819-FBEFA7A8-F747-410B-BE51-FB0F308CCC30Q45879327-B49951E1-6B39-47CD-A531-3EF41264C1DBQ49745450-946611E7-5538-460F-946F-1CB5838A311D
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Haemophilia care then, now and in the future.
@ast
Haemophilia care then, now and in the future.
@en
Haemophilia care then, now and in the future.
@nl
type
label
Haemophilia care then, now and in the future.
@ast
Haemophilia care then, now and in the future.
@en
Haemophilia care then, now and in the future.
@nl
prefLabel
Haemophilia care then, now and in the future.
@ast
Haemophilia care then, now and in the future.
@en
Haemophilia care then, now and in the future.
@nl
P2093
P1433
P1476
Haemophilia care then, now and in the future.
@en
P2093
P356
10.1111/J.1365-2516.2008.01946.X
P478
15 Suppl 1
P577
2009-01-01T00:00:00Z